AntriaBio, Inc. (ANTB) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 18 transactions totaling $76.1K, demonstrating a bullish sentiment with $76.1K in net insider flow. The most recent transaction on Mar 10, 2017 involved a purchase of 5,000 shares valued at $4.8K.
No significant insider buying has been recorded for ANTB in the recent period.
No significant insider selling has been recorded for ANTB in the recent period.
Based on recent SEC filings, insider sentiment for ANTB is bullish with an Insider Alignment Score of 100/100 and a net flow of $76.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AntriaBio, Inc. (ANTB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading ANTB stock, having executed 18 transactions in the past 90 days. The most active insider is David F. Welch (Executive), who has made 14 transactions totaling $76.1K.
Get notified when executives and directors at ANTB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 10, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.95 | $4.8K | |
| Mar 9, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.95 | $4.8K | |
| Mar 8, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.98 | $4.9K | |
| Mar 6, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.95 | $4.8K | |
| Feb 10, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.99 | $5.0K | |
| Feb 9, 2017 | F. Welch David | Executive | Purchase | 3,100 | $0.97 | $3.0K | |
| Feb 8, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.98 | $4.9K | |
| Feb 7, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.99 | $5.0K | |
| Jan 20, 2017 | F. Welch David | Executive | Purchase | 9,983 | $1.07 | $10.7K | |
| Jan 19, 2017 | F. Welch David | Executive | Purchase | 10,000 | $0.95 | $9.5K | |
| Jan 18, 2017 | F. Welch David | Executive | Purchase | 5,000 | $1.00 | $5.0K | |
| Jan 12, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.95 | $4.8K | |
| Jan 11, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.94 | $4.7K | |
| Jan 10, 2017 | F. Welch David | Executive | Purchase | 5,000 | $0.91 | $4.5K | |
| Feb 9, 2015 | C. Elam Nevan | Executive | Sale | 842,949 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 14 | $76.1K | 100.0% |
Sale(S) | 1 | $0 | 0.0% |
Award(A) | 3 | $0 | 0.0% |
Insiders at AntriaBio, Inc. are accumulating shares at an accelerated pace. With 4 insiders making 18 transactions totaling $76.1K in purchases versus $0 in sales, the net buying activity of $76.1K signals strong executive confidence. David F. Welch (Executive) leads the buying activity with $76.1K in transactions across all time.